BioPharma-Reporter » Biosimilars
184 FOLLOWERS
Take a peek into the news on the biopharmaceutical manufacturing industry, focusing on biologics, biosimilars, technology, upstream/downstream processing, cell culture, and regulations. William Reed's BioPharma-Reporter has been the leading online news source for the biopharma industry for more than 8 years, leveraging our digital-first position to bring powerful insights and robust..
BioPharma-Reporter » Biosimilars
5d ago
Thermo Fisherâs new state-of-the-art ultra-cold facility in Bleiswijk, Netherlands, aims to accelerate advanced therapies development by offering a comprehensive range of cold and ultra-cold services ..read more
BioPharma-Reporter » Biosimilars
5d ago
As investors and big pharma pile on developers of antibody-drug conjugates (ADCs), Bright Peak Therapeutics has attracted $90 million based on the promise of a related type of technology called immunoconjugates ..read more
BioPharma-Reporter » Biosimilars
5d ago
Alvotech of Iceland and STADA Arzneimittel of Germany have extended an existing partnership to co-develop a clinical-stage biosimilar for Prolia and Xgeva, Amgenâs therapies for bone conditions based on the antibody drug denosumab ..read more
BioPharma-Reporter » Biosimilars
5d ago
As the anticipation for the 60th DIA annual meeting reaches a fever pitch, eyes should be on Qinecsa, the latest breakthrough in clinical research technology ..read more
BioPharma-Reporter » Biosimilars
1w ago
In spite of their potential to tackle cancer in the long term, CAR-T cell therapies face challenges in terms of pricing, manufacturing and being limited to blood cancer ..read more
BioPharma-Reporter » Biosimilars
1w ago
GSK has acquired its San Diego-based collaborator Elsie Biotechnologies to strengthen its efforts in developing oligonucleotide therapeutics ..read more
BioPharma-Reporter » Biosimilars
1w ago
Keen to accelerate its drug development, the Japanese pharmaceutical group Kyowa Kirin will pump up to $530 million into building a biologics manufacturing plant in North Carolina, US ..read more
BioPharma-Reporter » Biosimilars
1w ago
Hikma Pharmaceuticals PLC has made a significant announcement, marking the US launch of Combogesic IV, an intravenous, opioid-free pain relief medication providing a multimodal approach to managing pain in adults ..read more
BioPharma-Reporter » Biosimilars
1w ago
Kyverna Therapeutics has unveiled compelling new data for its CAR T-cell therapy, KYV-101, which may revolutionize the treatment of autoimmune diseases ..read more
BioPharma-Reporter » Biosimilars
1w ago
CordenPharma, a global CDMO manufacturing complex drug substances and lipid nanoparticles (LNPs), has signed a partnership agreement with Certest, a Spanish company specializing in drug delivery and API synthesis ..read more